Mohamed A Elshaikh
Affiliation: Henry Ford Hospital
Feldman A, Chaugle S, Burmeister C, Munkarah A, Elshaikh M. A Matched Analysis on the Prognostic Impact of Race on Survival Endpoints of Women with Early-Stage Endometrial Cancer. Gynecol Obstet Invest. 2018;:1-7 pubmed publisher
..Based on these data, disparities in outcome likely do not stem from uterine cancer-related causes. The increased comorbidity burden in AA women is likely a factor contributing to the racial disparity in endometrial cancer. ..
Elshaikh M, Al Wahab Z, Mahdi H, Albuquerque K, Mahan M, Kehoe S, et al
. Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study. Gynecol Oncol. 2015;136:235-9 pubmed publisher
..There was no significant difference in the outcome between patients who received vaginal cuff brachytherapy compared to those who received pelvic external beam radiation treatment. ..
Doemer A, Chetty I, Glide Hurst C, Nurushev T, Hearshen D, Pantelic M, et al
. Evaluating organ delineation, dose calculation and daily localization in an open-MRI simulation workflow for prostate cancer patients. Radiat Oncol. 2015;10:37 pubmed publisher
..14 cm (left-right). This study confirms the potential of using an open-field MRI scanner as primary imaging modality for prostate cancer treatment planning simulation, dose calculations and daily image localization. ..
Kamal M, Burmeister C, Zhang Z, Munkarah A, Elshaikh M. Obesity and Lymphovascular Invasion in Women with Uterine Endometrioid Carcinoma. Anticancer Res. 2015;35:4053-7 pubmed
..97-0.99). Increased BMI was significantly associated with lower tumor grade and younger patient age at diagnosis. Increased body mass index was not associated with LVI. The higher prevalence of obesity in young women with EC is alarming. ..
Xu Y, Hanna R, Elshaikh M. Adjuvant therapy of uterine clear cell carcinoma: a review. Arch Gynecol Obstet. 2016;293:485-92 pubmed publisher
..UCCC-specific studies are needed to determine the best adjuvant therapy for UCCC without the confounding effects of USC and other endometrial cancers. ..
Al Feghali K, Elshaikh M. Why brachytherapy boost is the treatment of choice for most women with locally advanced cervical carcinoma?. Brachytherapy. 2016;15:191-9 pubmed publisher
Modh A, Ghanem A, Burmeister C, Rasool N, Elshaikh M. Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data. Brachytherapy. 2016;15:554-61 pubmed publisher
..In this large national database set, there continues to be an increasing trend for the use of VB in the adjuvant setting in women with early-stage endometrial carcinoma. ..
Isrow D, Burmeister C, Hanna R, Elshaikh M. Survival endpoints for young women with early stage uterine endometrioid carcinoma: a matched analysis. Eur J Obstet Gynecol Reprod Biol. 2016;207:115-120 pubmed publisher
..When matched based on tumor stage, grade and adjuvant management, our study suggests that there is no difference in survival endpoints between younger and older patients with early stage endometrial carcinoma. ..
Lee J, Ghanem A, Modh A, Burmeister C, Mahmoud O, Maxwell G, et al
. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis. Brachytherapy. 2018;17:319-325 pubmed publisher